Clinical Report: Evaluating the Safety of Prescription NSAIDs in IBD

Overview

This study evaluates the safety of prescription NSAIDs in adults with inflammatory bowel disease (IBD) using a large administrative claims database. Findings indicate that NSAID exposure was not significantly associated with increased IBD-related hospitalization in patients with ulcerative colitis.

Background

Musculoskeletal symptoms are prevalent in patients with IBD, and NSAIDs are often used for their analgesic properties. However, there are concerns regarding the potential for NSAIDs to trigger disease flares in IBD patients, leading to recommendations against their use based on historical data. Understanding the safety profile of NSAIDs in this population is crucial for managing pain while minimizing risks.

Data Highlights

No numerical data provided in the source material.

Key Findings

• NSAID exposure was not associated with a meaningful increase in IBD-related hospitalization in ulcerative colitis patients.
• Similar conclusions could not be definitively reached for patients with Crohn's disease.
• Over half of NSAID-exposed individuals had a recent code for joint or chronic musculoskeletal pain.
• Previous studies have shown mixed results regarding the risk of IBD flare associated with NSAID use.

Clinical Implications

Clinicians should consider the potential benefits of NSAIDs for managing musculoskeletal symptoms in IBD patients, particularly those with ulcerative colitis, while remaining aware of the existing guidelines against their use. Individual risk assessment is essential in determining the appropriateness of NSAID therapy.

Conclusion

The findings of this study contribute to the ongoing discussion regarding NSAID safety in IBD.

Related Resources & Content

1. Mayer et al., Arthritis Care & Research, 2026 -- Safety of Prescription Nonsteroidal Anti-inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort
2. Journal of Gastroenterology — An In-Depth Review of Small-Bowel Injury Associated with Non-Steroidal Anti-Inflammatory Drugs
3. BMJ Open Gastroenterology — Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review
4. Drug Safety — NSAID Use and Associated Upper Gastrointestinal Complications
5. Drug Safety — Evaluating Cardiovascular Risks Associated with Non-steroidal Anti-inflammatory Medications: Implications for Clinical Practice
6. NHS Shared-Care Guideline for Adult IBD
7. ECCO Guidelines on Therapeutics in Ulcerative Colitis
8. Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease - Mayer - 2026 - Arthritis Care & Research - Wiley Online Library
9. Safety of Prescription Nonsteroidal Anti‐inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort - Mayer - Arthritis Care & Research - Wiley Online Library
10. Safety of Prescription Nonsteroidal Anti‐inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort - Mayer - Arthritis Care & Research - Wiley Online Library
11. Postpartum nonsteroidal anti-inflammatory drug exposure does not increase risk for flare in patients with inflammatory bowel disease - PubMed
12. Nonsteroidal Anti‐Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta‐Analysis - Tawfik - 2026 - Clinical Pharmacology & Therapeutics - Wiley Online Library
13. Systematic Review and Meta-analysis: Association Between Acetaminophen and Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Crohn’s Disease and Ulcerative Colitis Exacerbation - PMC